DOCSLIB.ORG

DNA Script Raises $38.5 Million in Series B Financing

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DNA Script Raises $38.5 Million in Series B Financing DNA Script Raises $38.5 Million in Series B Financing Oversubscribed round led by LSP will fund accelerated product development and commercial operations in the U.S. PARIS, May 16, 2019 - DNA Script today announced an oversubscribed Series B fundraising of $38.5M led by LSP, one of Europe's largest and most experienced healthcare investment rms. Bpifrance, through its Large Venture fund, joined the round, alongside existing investors Illumina Ventures, M. Ventures, Sonnova Partners, Kurma Partners and Idinvest Partners. The proceeds will enable DNA Script to accelerate the development of the company's rst products based on its industry-leading enzymatic technology for de novo synthesis of nucleic acids. The company is prioritizing the recruitment of top talent in the U.S. for its product development and commercialization teams in preparation for product launch, as well as on expanding its Paris-based research team. DNA Script's innovative technology provides affordable, rapid, high-quality production of important genomic experimental precursors, such as oligonucleotides. The technology overcomes many of the ineciencies of today's synthetic DNA production. It features a novel biochemical process for nucleic acids synthesis based on the use of highly ecient enzymes, thus enabling enhanced performance while minimizing the use of harsh chemicals. The product portfolio based on DNA Script's proprietary enzymatic synthesis platform will enable molecular biology researchers to accelerate their experiments — with the goal of moving from design to results within a day for a broad range of applications. "In less than two years since our last nancing round, the DNA Script team has developed enzymatic synthesis technology at an incredibly fast pace and extended the company's lead in this exciting and quickly expanding sector. As we announced earlier this year at the AGBT General Meeting, DNA Script was the rst company to enzymatically synthesize a 200mer oligo de novo with an average coupling eciency that rivals the best organic chemical processes in use today. Our technology is now reliable enough for its rst commercial applications, which we believe will deliver the promise of same-day results to researchers everywhere, with DNA synthesis that can be completed in just a few hours," said Thomas Ybert, CEO and cofounder of DNA Script. "We are thrilled to lead this round with participation of such a respected group of founders and investors. We see DNA Script as the clear leader in this nascent eld," said Joachim (JR) Rothe, Managing Partner at LSP and new member of DNA Script's board. "The progress made by DNA Script in only two years is amazing, and we believe the company will shift the current DNA synthesis paradigm, not only in the research market but also in the broader pharma business — for personalized therapies and diagnostics in particular." About DNA Script Founded in 2014 in Paris, DNA Script is the world's leading company in manufacturing de novo synthetic nucleic acids using an enzymatic technology. The company aims at accelerating innovation in life sciences and technology through rapid, affordable, and high-quality DNA synthesis. DNA Script's approach leverages nature's billions of years of evolution in synthesizing DNA to enable genome scale synthesis. The Company's technology has the potential to greatly accelerate the development of new therapeutics, sustainable chemicals production, improved crops as well as data storage. www.dnascript.co About LSP LSP (Life Sciences Partners) is an independent European investment rm, providing nancing for private and public life sciences companies. LSP's mission is to connect investors to inventors, focusing on unmet medical needs. Since the late 1980s, LSP's management has invested in about 100 innovative enterprises, many of which have grown to become leaders of the global life sciences industry. With over €2.0 billion ($2.3 billion) of investment capital raised to date and oces in Amsterdam, Munich and Boston, LSP is one of Europe's leading life sciences investors. LSP also invests in public companies through its Euronext-listed LSP Life Sciences Fund (Bloomberg: LSP NA). For more information, please visit: www.lspvc.com About Bpifrance and the Large Venture fund Bpifrance is the French national investment bank: it nances businesses – at every stage of their development – through loans, guarantees, equity investments and export insurances. Bpifrance also provides extranancial services (training, consultancy...) to help entrepreneurs meet their challenges (innovation, export…). Large Venture is a EUR 1 billion fund dedicated to innovative companies in healthcare, IT and greentech sectors. The fund is able to invest amounts greater than EUR 10 million and thus ensures the equity nancing continuum of the venture capital actors who invest earlier in the development of the company. For more information, please visit: www.bpifrance.fr and presse.bpifrance.fr - Follow us on Twitter: @Bpifrance - @BpifrancePresse About Illumina Ventures Illumina Ventures is an independently-managed, healthcare-focused venture rm in a strategic partnership with Illumina, with the vision to unlock the power of the genome. As an early-stage, value-add investor, we help entrepreneurs develop breakthrough science and technologies into market-leading companies to transform healthcare. We focus on investment in life science tools, therapeutics, diagnostics, and personal wellness. www.illuminaventures.com About Sonnova Partners Sonnova Partners is a leading European venture capital rm specialized in Life Sciences. Based in Paris, France, the rm brings together a team of professionals from all over Europe, the US and China. The rm focuses on paradigm shifting technologies alongside visionary entrepreneurs. Sonnova Partners seeks to invest as a lead or cornerstone investor in seed, start-ups, corporate spin-offs and late stage companies. It has backed nearly 500 companies over more than 45 years, creating market leaders around the globe. Today, Sonnova Partners has over €1.9 billion under management. For more information: www.sonnova.fr. About M Ventures M Ventures is the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. Its mandate is to invest in innovative technologies and products with the potential to signicantly impact the company's core business areas. From its headquarters in Amsterdam and oces in the US and Israel, M Ventures invests globally in transformational ideas driven by great entrepreneurs. M Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. M Ventures has a signicant focus on early stage investing and company creation including the creation of spin-offs to leverage the company's science and technology base. For more information, visit www.m-ventures.com. About Kurma Partners Founded in 2009, Kurma Partners is a leading European venture capital rm investing in biotherapeutics (Kurma Biofund I, II and III) as well as in diagnostic and digital health (Kurma Diagnostics). Kurma is currently managing € 400 million. Kurma's unique investment strategy combines the creation of companies on most disruptive sciences and technologies, and the nancing of most promising venture-stage European companies. Kurma Partners operates from Paris, France (headquarters) and Munich, Germany. www.kurmapartners.com About Idinvest Partners Idinvest Partners is a leading European mid-market private equity rm. With €8bn under management, the rm has developed several areas of expertise including innovative startup venture capital transactions; mid-market private debt, i.e. single-tranche, senior and subordinated debt; primary and secondary investment and private equity advisory services. Founded in 1997, Idinvest Partners used to belong to the Allianz Group until 2010, when it branched out as an independent rm. In January 2018, Idinvest Partners became a subsidiary of Eurazeo, a leading global investment company, with a diversied portfolio of €17bn in assets under management, including approximately €11bn from investment partners, invested in over 350 companies. www.idinvest.com Press contacts in Europe ALIZE RP Caroline Carmagnol and Tatiana Vieira [email protected] 06 64 18 99 59 / 01 44 54 36 65 Press contact in the US SEISMIC Eric Schubert [email protected] +415-9394366 DNA Script Contact Sylvain Gariel, COO [email protected] © All Right Reserved. DNA Script .
Load more

Recommended publications
  • RI Transparency Report Is One of the Key Outputs of This Framework
    RI TRANSPARENCY REPO RT 2019 Idinvest Partners An investor initiative in partnership with UNEP Finance Initiative and UN Global Compact About this report The PRI Reporting Framework is a key step in the journey towards building a common language and industry standard for reporting responsible investment (RI) activities. This RI Transparency Report is one of the key outputs of this Framework. Its primary objective is to enable signatory transparency on RI activities and facilitate dialogue between investors and their clients, beneficiaries and other stakeholders. A copy of this report will be publicly disclosed for all reporting signatories on the PRI website, ensuring accountability of the PRI Initiative and its signatories. This report is an export of the individual Signatory organisation’s response to the PRI during the reporting period specified above. It includes their responses to mandatory indicators, as well as responses to voluntary indicators the signatory has agreed to make public. The information is presented exactly as it was reported. Where an indicator offers a response option that is multiple-choice, all options that were available to the signatory to select are presented in this report. Presenting the information exactly as reported is a result of signatory feedback which suggested the PRI not summarise the information. PRI disclaimer This document presents information reported directly by signatories. This information has not been audited by the PRI Secretariat or any other party acting on their behalf. While this information is believed to be reliable, no representations or warranties are made as to the accuracy of the information presented, and no responsibility or liability can be accepted for any error or omission.
    [Show full text]
  • Entrepreneurship in Spain
    All you need to know about entrepreneurship in Spain June 2021 edition A way to make Europe EUROPEAN REGIONAL DEVELOPMENT1 FUND CONTENT Part I – STARTING POINT • Creating a startup Part II – RESOURCES FOR STARTUPS • Resources for startups • Incubators • Accelerators • Specific services suppliers Part III – FINANCING FOR STARTUPS • How to obtain financing • Private sector • Public sector • European calls • National calls Part IV – EVENTS FOR STARTUPS • Events Part V – AUTONOMOUS REGIONS • Programs and subsidies for startups This guide is intended as a collection of resources for startups in their different stages of seeking public and/or private funding 2 Part I Starting point CREATING A STARTUP IN SPAIN The steps to establish a startup are the same as for any other company. The very first one is to determine the most appropriate legal form, a decision that will be influenced by the startup´s later needs regarding participation deals and receipt of third-party investment. The most used legal forms are: Spain • Limited Liability Company (Sociedad Limitada, S.L.) in • Corporation (Sociedad Anónima, S.A.). startup Both forms can also be set up as a sole-shareholder entity (Sociedad Anónima Unipersonal, S.A.U. and Sociedad Limitada Unipersonal, S.L.U. respectively) a at the time of incorporation or be converted into a sole-shareholder entity afterwards. While there are alternatives to these legal forms, they aren´t advisable for startups that will be seeking to add partners to the project and/or third-party investors. For information purposes, these include: Freelancer (Autónomo), Private partnership (Sociedad Civil) or Jointly-Owned Entity (Comunidad de creating Bienes), or a Cooperative (Cooperativa).
    [Show full text]
  • Monthly European
    December 2013 Technology / Media / Telecoms / Internet / Healthcare / Cleantech / Materials Go4Venture Advisers’ European Venture & Growth Equity Market Monthly Bulletin December 2013 Published by Go4Venture Advisers Research, the Equity Research unit of Go4Venture Advisers LLP. About Go4Venture Advisers Providing innovative, fast-growing companies and their investors with independent corporate finance advice to help them evaluate, develop and execute growth strategies Equity Capital Markets (ECM) Equity private placements Growth equity financings and secondaries Pre-IPO advisory Mergers & Acquisitions (M&A) Sellside Buyside / Buy and build Valuation services Go4Venture Advisers LLP is authorised and regulated by the Financial Conduct Authority (FCA). © Go4Venture Advisers 2013 December 2013 Contents This Month in Brief 2 Investments 1.1 - Headline Transactions Index (HTI) 5 1.2 - Large Transactions Summary 6 1.3 - Large Transactions Profiles 7 M&A Transactions 2.1 - M&A Activity Index 17 2.2 - Top 5 Global TMT M&A Transactions Summary 18 Headline European VC & PE-Backed M&A Transactions: 2.3 - Summary 21 2.4 - Profiles 22 List of Acronyms 25 About this Bulletin The Go4Venture Advisers’ European Venture & Growth Equity Market Monthly Bulletin provides a summary of corporate finance activity among emerging European TMT companies: Investments, i.e. Venture Capital (VC) and Private Equity (PE) financings, including growth equity, financing rounds with single secondaries components (recapitalisations); and M&A Transactions where the sellers are VC and PE-backed European companies, including all majority transactions with no new investment going into the business (e.g. acquisitions, Management Buyouts (MBOs) and other buyouts). Investment activity is measured using Go4Venture’s European Tech Headline Transactions Index (HTI), which is based on the number and value of transactions reported in professional publications.
    [Show full text]
  • 2021 Shareholders' Meeting
    2021 Shareholders’ Meeting APRIL 28, 2021 3 OPENING OF THE SHAREHOLDERS’ MEETING Michel David-Weill Chairman of the Supervisory Board 2021 SHAREHOLDERS’ MEETING 4 LEGAL FORMALITIES Nicolas Huet General Counsel 2021 SHAREHOLDERS’ MEETING PRESENTATION BY THE 1 CHAIRMAN OF THE 2 A NEW IDENTITY SUPERVISORY BOARD FOR A NEW AMBITION Michel David-Weill Virginie Morgon, Chief Executive Officer 3 SOLID PERFORMANCE 4 AN AMBITIOUS STRATEGY: IN 2020 POWER BETTER GROWTH Philippe Audoin, Virginie Morgon, Chief Financial Officer Chief Executive Officer Agenda PRESENTATION OF THE PRESENTATION 6 WORK OF THE CAG FOR THE 5 OF THE SUPERVISORY COMMITTEE BOARD’S WORK Georges Pauget, Chairman of the SHAREHOLDERS’ Nicolas Huet, Compensation, Appointment MEETING General Secretary and Governance Committee PRESENTATION 8 SHAREHOLDERS’ 7 OF THE STATUTORY QUESTIONS AUDITORS’ REPORTS Isabelle Massa Mazars, for the joint auditors PRESENTATION 9 OF THE RESOLUTIONS Nicolas Huet, General Secretary 2021 SHAREHOLDERS’ MEETING 2021 Shareholders’ Meeting APRIL 28, 2021 PRESENTATION BY THE 1 CHAIRMAN OF THE SUPERVISORY BOARD Michel David-Weill 2021 SHAREHOLDERS’ MEETING 9 2 A NEW IDENTITY FOR A NEW AMBITION Virginie Morgon Chief Executive Officer 2021 SHAREHOLDERS’ MEETING A NEW BRAND IDENTITY 10 TO BUILD EURAZEO’S POSITIONING FOR 2030 ? 2001PASSIVE HOLDING 2011FRENCH INVESTMENT 2021EUROPEAN ASSET COMPANY FIRM MANAGER with a minority exposure focused on listed with a diversified mix to listed and unlisted French and unlisted large-cap of investments, backed assets companies
    [Show full text]
  • Investor Presentation, July 2018 Source: Factset As at November 16, 2018; Thomson One; Bloomberg, Q3 Report
    Investor Investor 2018 presentation Investor Day 7th December Eurazeo is ready to grow Virginie Morgon, CEO Agenda 2018 INVESTOR DAY Eurazeo, a large diversified multi-specialist European asset manager p. 8 Solid fundraising capacity ready to grow AuM p. 44 Eurazeo: Idinvest, integrating with Eurazeo p. 54 ready to grow Financial reporting for Eurazeo p. 74 Private debt p. 96 Private funds group p. 112 A deep dive Real assets p. 128 into our asset classes Private equity p. 149 Strong leadership 20+ years in the industry Executive Committee Executive Board Virginie MORGON Marc FRAPPIER PARTNERS CEO Managing Partner – Head of Eurazeo Capital Christophe BAVIERE Benoist GROSSMANN CEO Managing Partner Philippe AUDOUIN Frans TIELEMAN Head of Venture & Growth Directeur Général Managing Partner - Member of the Executive Board Finances - CFO Head of Eurazeo Development Nicolas HUET Renaud HABERKORN General Secretary Managing Partner - Head of Eurazeo Patrimoine Steven LANGMAN Robert AGOSTINELLI Olivier MILLET Caroline HADRBOLEC Co-Founder and Chairman Of the Chief Human Resources Co-Founder and Managing Director Managing Director Executive Board Officer Of Eurazeo PME Eurazeo 2018 Investor Day 4 Our messages Our industry is growing and should continue to do so Our model of balance sheet and third party AuM is uniquely differentiated We are today a large diversified multi-specialist European asset manager Our ambition is global Each of our investment divisions has standalone excellence and ready to grow Eurazeo 2018 Investor Day 5 Global 90+ footprint 380+ 4 230+ investment portfolio asset professionals professionals 9 countries companies classes WE ARE BORN FRENCH OUR SUCCESS IS EUROPEAN OUR AMBITION IS GLOBAL €5bn €17bn €6bn 2x market AuM NAV average CoC capitalisation All partially & fully realised exits since 2002 (…) Nb.
    [Show full text]
  • Preqin Special Report: the Private Debt Top 100
    PREQIN SPECIAL REPORT: THE PRIVATE DEBT TOP 100 ■ The 100 Largest Fund Managers ■ The 100 Largest Institutional Investors AUGUST 2018 PREQIN SPECIAL REPORT: THE PRIVATE DEBT TOP 100 FOREWORD s reported in the 2018 Preqin Global Private Debt Report, the private debt asset class in 2017 was characterized by a trend Atowards greater capital concentration: 17% fewer funds reached a final close than in 2016, while a record $107bn was secured among fund managers. Average fund size increased to $869mn, a leap of $171mn from the previous year. Capital remains concentrated among the top GPs, as the 10 largest funds closed in 2017 secured over a third of total capital raised in the year. Institutional investor appetite for the private debt asset class is strong, with 98% of investors surveyed by Preqin at the end of 2017 planning to increase or maintain their private debt allocations in the long term. The 100 largest private debt LPs have a combined $172bn invested in the asset class, which represents nearly a quarter (22%) of all capital invested in the space. The top LPs are the main drivers behind the growth in prominence of the largest fund managers, as they require GPs to be of sufficient scale to accept and deploy increasingly large commitments. With the objective of providing greater insight into who the most influential players are, Preqin is pleased to provide a comprehensive ranking for the first time of the top 100 GPs and LPs within the private debt asset class, taken from our platform. For the purpose of this report, the GP rankings have been compiled based on the total value of private debt funds raised by each GP in the past 10 years – this includes any capital raised by owned subsidiaries.
    [Show full text]
  • Startup Financing in Spain. 2015 (VC, Business Angels, Accelerators, Loans)
    ENGLISH EDITION Startup Financing in Spain. 2015 (VC, Business Angels, Accelerators, Loans) SPONSORED BY - - WEBCAPITALRIESGO Copyright © 2015, Webcaprisk Servicios, S.L. Total or partial reproduction of this document is strictly forbidden, as is its manipulation with software or transmission in any form via any medium, be it electronic, through photo- copying or other means without the previous permission of the Copyright holder. Access to Startup Financing in Spain. 2015 report is free at www.webcapitalriesgo.com; this may not be made available to the public through any other means, electronic or written, without the written permission of the rights holder. Any infringiment of the above rights will be liable to claims presented before the Madrid Courts (Spain). Startup Financing in Spain. 2015. June 2015. Release 1.0 Webcaprisk Servicios S.L. is the owner of www.webcapitalriesgo.com - 2 - WEBCAPITALRIESGO INTRODUCTION The financing of high-growth, high-potential and mostly early stage firms shows a persis- tent positive evolution in Spain. Startup firms have now access to several sources of long- term financing such as subsidized and participative loans granted by public-sector institu- tions (e.g., CDTI, ENISA and other similar institutions), domestic and international ventu- re capital firms (VCFs), and organized Business Angels, accelerators, incubators and simi- lar entities. International funds continued to show a noticeable interest in investing in our country. If in 2013 17 funds (an historical maximum) invested in Spain for the first time, last year there were 14. These are amazing figures when we bear in mind that in the years prior to this the average was around 5.
    [Show full text]
  • Post-Investment and ESG Reporting
    Table of contents 1. Editorial ...............................................................................................................................................................................p.7 2. Idinvest Partners’ Sustainability & Impact policy ........................................................................................p.9 Idinvest Partners: A responsible investor .......................................................................................................p.9 Responsible Private Equity policy .....................................................................................................................p.10 Public commitments by Idinvest Partners ......................................................................................................p.10 A team dedicated to addressing Sustainability & Impact issues .........................................................p.11 3. Impact of direct investments on the Sustainable Development Goals .............................................p.13 Scope of the analysis .............................................................................................................................................p.13 Impact assessment: Methodology and findings .........................................................................................p.14 1| Responsible, transparent governance bodies ............................................................................p.17 2| Decent work and equal opportunity .............................................................................................p.18
    [Show full text]
  • Idinvest and Eurazeo Join Forces
    IDINVEST AND EURAZEO JOIN FORCES Paris, February 5, 2018 - Eurazeo and Idinvest Partners (“Idinvest”) have announced the conclusion of a firm agreement that will create a private equity leader, with over €15 billion under management and serving the growth needs of companies in Europe and North America. Under the terms of this agreement, IDI, an investment company listed on Euronext Paris, has undertaken to sell its entire investment in Idinvest (i.e 51% of the share capital) to Eurazeo, which will subsequently own about 70% of the company, next to the Idinvest’s management who will retain around 30%. The transaction represents a total investment for Eurazeo of approximately €230 million, setting an enterprise value of €310 million on Idinvest. Completion is subject to regulatory, competition and other conditions precedent. The parties have also signed intentions of buying and selling, with a view to Eurazeo gradually acquiring the remaining shares held by Idinvest’s management over the coming years. Idinvest finances companies at different stages of the growth curve across France and Europe, its business lines therefore complementing those of Eurazeo. Idinvest’s Venture and Growth Capital teams make equity investments in young, innovative companies with significant growth potential and, most notably, have participated in historic tech and digital successes such as Deezer, Criteo, Talend, Winamax and Vestiaire Collective. Idinvest’s Private Debt business finances organic and external growth projects for SMEs and mid-caps by providing senior or subordinated debt. Finally, the Mandates and Dedicated Funds team manages private equity fund investment programs and performs secondary transactions and direct co-investments.
    [Show full text]
  • NEWS COMPENDIUM Tracking the Dynamic Secondaries Market Across Asset Classes Contents
    www.secondariesinvestor.com NEWS COMPENDIUM Tracking the dynamic secondaries market across asset classes contents Headlines Q&A Welcome Temasek’s Astrea II Catching up with Dear reader, nearly $1bn in size CalPERS Welcome to our special Réal Desrochers, head of private Motion Equity restructuring equity for the $277bn California Secondaries Investor compendium. cost $430m Public Employees’ Retirement System, talks us through the Regular visitors to our Pantheon: restructurings benchmark LP’s secondaries website will know we offer worth $70.5bn strategy. a unique daily mix of stories, often providing new details Coller’s next fundraise Spinning out and key insights on market expected this year Andrew Dewar, managing developments. We track partner of Barclays Africa spin-out the institutions, funds and UK mulls $760m fund Rockwood Private Equity, talks us transactions shaping the interests sale through his firm’s spin-out. secondaries markets within private equity, real estate, Metropolitan to target infrastructure and private debt. real estate Secondaries UBS on $45bn in dry powder We also showcase hand- National Bank of Greece Rodney Reid, UBS’ head of selected, third-party secondaries advisory for EMENA, seeks buyer for PE spin-out commentary and research from discusses trends shaping the market this year. industry thought leaders on a Buyers lower weekly basis. return expectations The private (equity) This compendium collates some ADIA eyes fund life of banks of the most interesting – and restructurings Coller Capital chief executive most popular – items we’ve officer Tim Jones explains the published recently, giving you Cogent founder cycles of regulation that could an informative snapshot of launches new firm lead to banks re-joining the buy- today’s secondaries markets.
    [Show full text]
  • European Private Equity Market Outlook for 2012
    European Private Equity Market Outlook for 2012 May 2012 European Private Equity Market Outlook for 2012 DISCLAIMER This study has been prepared by Idinvest Partners and/or its affiliates (“Idinvest Partners”) for the exclusive use of the party to whom Idinvest Partners delivers this presentation (together with its subsidiaries and affiliates, the “Company”) using information provided by the Company and other publicly available information. The valuations, forecasts, estimates, opinions and projections contained herein involve elements of subjective judgment and analysis. This material is for information and illustrative purposes only, is not investment advice and is no assurance of actual future performance or results of any Private Equity segment or fund. Any information or opinion expressed herein is subject to change without notice. Nothing contained herein is, or shall be relied upon as, a promise or representation as to the past or future. Idinvest Partners, its affiliates, directors, officers, employees and/or agents expressly disclaim any and all liability relating or resulting from the use of all or any part of this study. This study has been prepared solely for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. The Company should not construe the contents of this presentation as legal, tax, accounting or investment advice or a recommendation. The Company should consult its own counsel, tax and financial advisors as to legal and related matters concerning any transaction described herein. This study does not purport to be all-inclusive or to contain all of the information that the Company may require.
    [Show full text]
  • Eurazeo’S Corporate Social 5.5 Five-Year Financial Summary (Article R
    2018 Registration document Annual Financial Report CONTENTS Group overview 3 Company financial statements 297 1 The strength of a unique model 20 5 5.1 Balance Sheet 298 A multi-expertise strategy 26 5.2 Income Statement 300 Scope of a global group 38 5.3 Notes to the Company financial statements 301 5.4 Statutory Auditors’ report on the financial statements 327 Eurazeo’s Corporate Social 5.5 Five-year financial summary (Article R. 225-102 of the French Commercial Code) 330 Responsibility 77 5.6 Customer and supplier settlement periods 331 2 2.1 A proactive CSR strategy 78 2.2 Non-Financial Performance Statement 92 Information on the Company 2.3 Methodology 117 and the share capital 333 2.4 Statutory Auditors’ reports 120 6 6.1 Information on the Company – Bylaws 334 6.2 Information on the share capital 340 6.3 Shareholding structure 344 Governance 125 6.4 Shareholders’ agreements 348 3 3.1 Management and Supervisory Bodies 126 6.5 Transactions in the Company’s shares 351 3.2 Compensation and other benefits received 6.6 Factors affecting a potential takeover bid 354 by corporate officers 165 6.7 Additional information 357 3.3 Interests held by members of the Supervisory and Executive Boards in the Company’s share capital and transactions in the Company’s shares by members of the Supervisory and Executive Boards 187 3.4 Risk management, internal control and main risk factors 189 Shareholders’ Meeting 361 3.5 Commitments under co-investment plans 204 7 7.1 Special Report on share subscription and purchase options (Article L.
    [Show full text]